Keyphrases
AIDS/HIV
62%
Antiretroviral Therapy
44%
HIV Patients
34%
Human Immunodeficiency Virus Type 1 (HIV-1)
28%
Fluconazole
28%
HIV Infection
24%
Amphotericin B
24%
Human Immunodeficiency Virus Infection
20%
Opportunistic Infections
20%
Cryptococcal Meningitis
18%
Protease Inhibitors
18%
Highly Active Antiretroviral Therapy (HAART)
18%
CD4 Count
16%
Cryptococcosis
15%
Confidence Interval
14%
People Living with HIV (PLHIV)
14%
Cryptococcal Infection
14%
Osteoporosis
12%
Histoplasmosis
12%
Zidovudine
11%
Itraconazole
11%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
9%
Insulin Resistance
9%
Cerebrospinal Fluid
9%
Pseudomonas Aeruginosa (P. aeruginosa)
9%
Ritonavir
8%
Risk Factors
8%
COVID-19
8%
Pneumocystis Jirovecii
8%
Clinical Trials
7%
Cytomegalovirus
7%
T Cells
7%
Epidemiology
7%
High Risk
7%
St. Louis
7%
Infectious Diseases
7%
Candidemia
7%
Antiretroviral
7%
Infectious Diseases Society of America
6%
HIV-1 Infection
6%
Infected Patients
6%
Candidiasis
6%
Cytomegalovirus Disease
6%
Fungal Infection
6%
Ireland
6%
HIV Viral Load
6%
Dyslipidemia
5%
Efavirenz
5%
Osteopenia
5%
Infected Individual
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Human Immunodeficiency Virus Infection
33%
Infection
28%
Diseases
26%
Fluconazole
26%
Proteinase Inhibitor
18%
Amphotericin B
17%
Clinical Trial
14%
Opportunistic Infection
14%
Cryptococcal Meningitis
14%
Acquired Immune Deficiency Syndrome
14%
Itraconazole
10%
Zidovudine
10%
Human Immunodeficiency Virus 1
10%
Candida
9%
Histoplasmosis
8%
Prevalence
8%
Nonnucleoside Reverse Transcriptase Inhibitor
8%
Mycosis
7%
Placebo
7%
Bloodstream Infection
7%
Candidemia
7%
Candidiasis
6%
Efavirenz
5%
Pharmacokinetics
5%
Osteopenia
5%
Cotrimoxazole
5%
Oropharynx Candidiasis
5%
Nelfinavir
5%
Bone Disease
5%
Medicine and Dentistry
Human Immunodeficiency Virus
72%
Infection
24%
Antiretroviral Therapy
24%
Human Immunodeficiency Virus Infection
21%
Diseases
19%
Amphotericin B
13%
Proteinase Inhibitor
12%
COVID-19
12%
Cryptococcosis
11%
Infectious Disease
10%
Cryptococcal Meningitis
9%
Highly Active Antiretroviral Therapy
9%
Acquired Immune Deficiency Syndrome
8%
Opportunistic Infection
8%
Fluconazole
7%
Insulin Resistance
7%
Cytomegalovirus Infection
7%
Histoplasmosis
6%
Clinical Trial
6%
Central Nervous System
6%
Ritonavir
5%
Osteoporosis
5%
Cerebrospinal Fluid
5%